139 related articles for article (PubMed ID: 19982552)
1. Splenomedullary Leukæmia.
Smith EB
Proc R Soc Med; 1922; 15(Sect Study Dis Child):1. PubMed ID: 19982552
[No Abstract] [Full Text] [Related]
2. A Case of Acute Ménière's Symptoms in Splenomedullary Leucocythæmia, with Special Reference to the Anatomical Changes found in Acute Leucocythæmic Affections of the Ear: Including a Pathological Report on the Present Case.
Weber FP; Lake R
Med Chir Trans; 1900; 83():185-208.3. PubMed ID: 20896948
[No Abstract] [Full Text] [Related]
3. [Splenomedullary syndromes. Part II. ].
BOSCH RG
Dia Med; 1952 Sep; 24(56):1456-61. PubMed ID: 13020748
[No Abstract] [Full Text] [Related]
4. [Splenomedullary syndromes. Part I].
GONZALEZ BOSCH R
Dia Med; 1952 Aug; 24(55):1421-7. PubMed ID: 13020741
[No Abstract] [Full Text] [Related]
5. [Mycolytic hypoleukemic mesolysis evolving for more than 13 years].
PICARD B; HOREAU J; KERNEIS
Sang; 1947; 18(2):121-4. PubMed ID: 20257352
[No Abstract] [Full Text] [Related]
6. Leukaemia cutis for clinicians, a literature review.
Osmola M; Gierej B; Kłosowicz A; Waszczuk-Gajda A; Basak GW; Jędrzejczak WW; Jurczyszyn A; Ziarkiewicz-Wróblewska B
Postepy Dermatol Alergol; 2021 Jun; 38(3):359-365. PubMed ID: 34377113
[TBL] [Abstract][Full Text] [Related]
7. Leukaemia-associated antigen (LAA) in proliferative blood disorders.
Stavem P; Berg K; Noer G
Scand J Haematol; 1977 Jan; 18(1):13-9. PubMed ID: 265091
[TBL] [Abstract][Full Text] [Related]
8. Uncommon Haematological Transformation: Chronic Myeloid Leukaemia Transitioning Into Plasma Cell Leukaemia in a Single Patient.
Jain MA; Acharya S; Pal AS; Raut L
Cureus; 2024 Jan; 16(1):e51639. PubMed ID: 38318562
[TBL] [Abstract][Full Text] [Related]
9. Leukaemia Infection Diagnosis and Intestinal Flora Disorder.
Wang H; Zhong Y; Ma L
Curr Mol Med; 2022; 22(1):2-7. PubMed ID: 33653248
[TBL] [Abstract][Full Text] [Related]
10. A comparison of the Antileukaemic Effects of Recombinant Human Tumour Necrosis Factor-alpha and its Muteins on Leukaemia L1210 and Leukaemia P388 in Mice.
Warzocha K; Góra-Tybor J; Kwinkowski M; Szymańska B; Robak T
Mediators Inflamm; 1994; 3(6):411-4. PubMed ID: 18475588
[TBL] [Abstract][Full Text] [Related]
11. T and B origin of human lymphocytic leukaemia.
Sabolović D
Cytobios; 1975; 12(46):79-88. PubMed ID: 1081030
[TBL] [Abstract][Full Text] [Related]
12. Leukaemia cutis in a patient with acute myelogenous leukaemia: case report.
Ogunbiyi AO; Shokunbi WA; Fasola FA; Ogunbiyi JO
East Afr Med J; 2003 Nov; 80(11):606-8. PubMed ID: 15248683
[TBL] [Abstract][Full Text] [Related]
13. Acute myeloid leukaemia of donor cell origin developing 17 years after allogenic hematopoietic cell transplantation for acute promyelocytic leukaemia.
Jiménez P; Alvarez JC; Garrido P; Lorente JA; Palacios J; Ruiz-Cabello F
Int J Biomed Sci; 2012 Dec; 8(4):244-8. PubMed ID: 23675279
[TBL] [Abstract][Full Text] [Related]
14. Acute leukaemia in children with Down syndrome in a low middle-income country.
Ul-Ain R; Faizan M; Anwar S; Riaz S; Ahmad A; Zafar H; Shamim W
Ecancermedicalscience; 2022; 16():1374. PubMed ID: 35702410
[TBL] [Abstract][Full Text] [Related]
15. Oral manifestations as an early clinical sign of acute myeloid leukaemia: a case report.
Guan G; Firth N
Aust Dent J; 2015 Mar; 60(1):123-7. PubMed ID: 25721286
[TBL] [Abstract][Full Text] [Related]
16. Dendritic cell-based immunotherapy in acute and chronic myeloid leukaemia.
Westers TM; Ossenkoppele GJ; van de Loosdrecht AA
Biomed Pharmacother; 2007 Jul; 61(6):306-14. PubMed ID: 17368821
[TBL] [Abstract][Full Text] [Related]
17. Leukaemia and transient leukaemia in Down syndrome.
Iselius L; Jacobs P; Morton N
Hum Genet; 1990 Oct; 85(5):477-85. PubMed ID: 2146208
[TBL] [Abstract][Full Text] [Related]
18. Early central nervous system involvement in adults with acute non-myelogenous leukaemia.
Lister TA; Whitehouse JM; Beard ME; Paxton A; Brearley RL; Brown L; Wrigley PF; Crowther D
Br J Cancer; 1977 Apr; 35(4):479-83. PubMed ID: 265731
[TBL] [Abstract][Full Text] [Related]
19. A Rare Case of an Elderly Male with Progression to Chronic Myeloid Leukaemia Secondary to Chronic Lymphocytic Leukaemia.
Saowapa S; Pangkanon W; Adu Y; Chaisrimaneepan N; Olavarria Bernal D; Polpichai N; Siladech P; Sekhon J
Eur J Case Rep Intern Med; 2024; 11(4):004297. PubMed ID: 38584899
[TBL] [Abstract][Full Text] [Related]
20. Retroviral sero-reactivity in LGL leukaemia patients and family members.
Nyland SB; Feith DJ; Poss M; Olson TL; Krissinger DJ; Poiesz BJ; Ruscetti FW; Loughran TP
Br J Haematol; 2020 Feb; 188(4):522-527. PubMed ID: 31608437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
